| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.95e-06 | 5 | 148 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | ZXDC SYNPO2 TCOF1 SH3KBP1 NBN WWTR1 CCND1 ZFPM1 DZIP1 HCN2 DCTN1 ZXDA TAF6L PTPN14 SNW1 SHANK2 NFATC2 LTBP1 SPEN GCN1 HCFC1 MAML3 TP53BP1 | 1.62e-04 | 1356 | 148 | 23 | GO:0060090 |
| GeneOntologyCellularComponent | transcription repressor complex | 3.72e-05 | 87 | 149 | 6 | GO:0017053 | |
| GeneOntologyCellularComponent | manchette | 4.44e-05 | 28 | 149 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | axon | CACNA1B SPAST DSCAM MYCBP2 CYP17A1 KATNB1 VPS16 PTCH1 HCN2 DCTN1 ATL1 STIM1 SHANK2 FEZ1 ROBO2 HCFC1 DYNC1H1 HSPB1 | 6.66e-05 | 891 | 149 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network | 6.72e-05 | 31 | 149 | 4 | GO:0071782 | |
| GeneOntologyCellularComponent | nuclear body | SART3 ZBTB16 CCNDBP1 BMP2K NBN WWTR1 DZIP1 BHLHE40 SNW1 GLI3 BANP CSTF2 CDT1 MAML3 TP53BP1 SON KIF22 SYMPK | 7.90e-05 | 903 | 149 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.58e-04 | 161 | 149 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | dynein complex | 5.94e-04 | 54 | 149 | 4 | GO:0030286 | |
| MousePheno | ectopic manchette | 1.75e-05 | 19 | 119 | 4 | MP:0009377 | |
| MousePheno | abnormal manchette morphology | 3.82e-05 | 45 | 119 | 5 | MP:0009376 | |
| MousePheno | mandibular cyst | 7.19e-05 | 2 | 119 | 2 | MP:0030220 | |
| MousePheno | jaw cyst | 7.19e-05 | 2 | 119 | 2 | MP:0030219 | |
| Domain | ARM-type_fold | UBQLN1 COPG1 ARMH1 HUWE1 PAIP1 ARVCF PIK3C3 TTC12 UTP20 PDS5A USP35 GCN1 GPRASP2 SYMPK | 4.49e-07 | 339 | 146 | 14 | IPR016024 |
| Domain | ARM-like | COPG1 ARMH1 HUWE1 ARVCF TTC12 UTP20 PDS5A USP35 GCN1 GPRASP2 SYMPK | 9.19e-06 | 270 | 146 | 11 | IPR011989 |
| Domain | Dynein_HC_stalk | 1.60e-04 | 14 | 146 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.60e-04 | 14 | 146 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.60e-04 | 14 | 146 | 3 | PF08393 | |
| Domain | MT | 1.60e-04 | 14 | 146 | 3 | PF12777 | |
| Domain | FN3 | 1.73e-04 | 199 | 146 | 8 | PS50853 | |
| Domain | DHC_fam | 1.99e-04 | 15 | 146 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.99e-04 | 15 | 146 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.99e-04 | 15 | 146 | 3 | IPR004273 | |
| Domain | FN3_dom | 2.42e-04 | 209 | 146 | 8 | IPR003961 | |
| Domain | - | 3.63e-04 | 222 | 146 | 8 | 1.25.10.10 | |
| Domain | SH3_2 | 5.71e-04 | 86 | 146 | 5 | PF07653 | |
| Domain | SH3_2 | 5.71e-04 | 86 | 146 | 5 | IPR011511 | |
| Domain | FN3 | 6.37e-04 | 185 | 146 | 7 | SM00060 | |
| Pubmed | TTC28 TCOF1 GAPDH MYCBP2 PSMC2 NBN WWTR1 HUWE1 DCTN1 PTPN14 SNW1 TET1 CSTF2 TAF1 SPEN GCN1 HCFC1 DYNC1H1 TP53BP1 SYMPK | 4.05e-13 | 549 | 151 | 20 | 38280479 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SART3 COPG1 TRO WWTR1 HUWE1 SIX4 RRBP1 DCTN1 IARS2 ZFHX4 NFATC2 BANP UTP20 PDS5A CCAR2 ASXL2 SPEN HCFC1 DYNC1H1 TP53BP1 KIF22 SYMPK | 2.45e-11 | 857 | 151 | 22 | 25609649 |
| Pubmed | SART3 COPG1 TCOF1 MYCBP2 PSMC2 HUWE1 STAU1 IARS2 SNW1 UTP20 PDS5A CCAR2 SPEN GCN1 HCFC1 DYNC1H1 TP53BP1 SON SYMPK | 7.71e-11 | 653 | 151 | 19 | 22586326 | |
| Pubmed | DSCAM TTC28 COPG1 BMP2K TCOF1 GAPDH HUWE1 ARFIP1 DNAH7 STIM1 IARS2 ARFGAP3 GLI3 PEX5 PDS5A CCAR2 SPEN GCN1 DYNC1H1 HSPB1 | 2.04e-10 | 777 | 151 | 20 | 35844135 | |
| Pubmed | TTC28 MYCBP2 CCDC174 NBN HUWE1 RRBP1 PAIP1 ATL1 STRIP2 STAU1 IARS2 ARFGAP3 N4BP2 BANP CSTF2 PEX5 CCAR2 CDT1 HCFC1 | 5.33e-10 | 733 | 151 | 19 | 34672954 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SART3 COPG1 PSMC2 VPS16 HUWE1 DCTN1 STAU1 RAB3GAP1 IARS2 UTP20 PDS5A GCN1 DHX29 HCFC1 DYNC1H1 TP53BP1 SON | 1.30e-08 | 704 | 151 | 17 | 29955894 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 COPG1 GAPDH MYCBP2 PSMC2 VPS16 HUWE1 RRBP1 DCTN1 STAU1 RAB3GAP1 PTPN14 SNW1 ARVCF UTP20 PDS5A CCAR2 GCN1 DHX29 DYNC1H1 HSPB1 TP53BP1 SON | 2.28e-08 | 1353 | 151 | 23 | 29467282 |
| Pubmed | SART3 UBQLN1 GAPDH PSMC2 HUWE1 DCTN1 PTPN14 PDS5A CCAR2 GCN1 HCFC1 DYNC1H1 KIF22 | 2.36e-08 | 399 | 151 | 13 | 37536630 | |
| Pubmed | SART3 CACNA1B SPAST COPG1 GAPDH MYCBP2 SH3KBP1 PSMC2 HUWE1 RRBP1 ATL1 STAU1 STIM1 RAB3GAP1 SHANK2 MECR ARFGAP3 GCN1 DHX29 HSPB1 TP53BP1 | 2.53e-08 | 1139 | 151 | 21 | 36417873 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | COPG1 HUWE1 SNW1 PDS5A CCAR2 TAF1 GCN1 HCFC1 DYNC1H1 HSPB1 TP53BP1 SYMPK | 2.69e-08 | 332 | 151 | 12 | 32786267 |
| Pubmed | Primary cilia and Gli3 activity regulate cerebral cortical size. | 1.58e-07 | 29 | 151 | 5 | 21976438 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RNF168 TCOF1 NBN WWTR1 REST SIX4 RRBP1 BHLHE40 TAF6L SNW1 BANP CSTF2 UTP20 PDS5A ASXL2 SPEN HCFC1 HSPB1 SON KIF22 SYMPK | 2.14e-07 | 1294 | 151 | 21 | 30804502 |
| Pubmed | CCDC174 SH3KBP1 PSMC2 NBN SIX4 STAU1 TAF6L SNW1 ZFHX4 GLI3 BANP CSTF2 PDS5A CCAR2 ASXL2 TAF1 SPEN HCFC1 DYNC1H1 RAI2 TP53BP1 SYMPK | 2.62e-07 | 1429 | 151 | 22 | 35140242 | |
| Pubmed | SART3 COPG1 TCOF1 GAPDH PSMC2 DCTN1 STAU1 PDS5A CCAR2 GCN1 HCFC1 HSPB1 TP53BP1 | 2.77e-07 | 494 | 151 | 13 | 26831064 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCOF1 MYCBP2 NBN ZFPM1 REST HUWE1 RRBP1 UTP20 CCAR2 CDT1 SPEN DHX29 HSPB1 TP53BP1 SON SYMPK | 2.93e-07 | 774 | 151 | 16 | 15302935 |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 3.20e-07 | 4 | 151 | 3 | 19091768 | |
| Pubmed | 3.78e-07 | 104 | 151 | 7 | 10470851 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 SYNPO2 CUX2 UBQLN1 TCOF1 TRO PTCH1 PAIP1 PEX5 SPEN DYNC1H1 SON | 4.37e-07 | 430 | 151 | 12 | 35044719 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | SART3 TCOF1 MYCBP2 CCND1 HUWE1 PTCH1 GLI3 CDT1 TAF1 DYNC1H1 SON | 5.25e-07 | 358 | 151 | 11 | 32460013 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TCOF1 GAPDH MYCBP2 HUWE1 RRBP1 STAU1 TAF6L SNW1 CSTF2 PEX5 UTP20 CCAR2 SPEN GCN1 TAP1 DYNC1H1 SON KIF22 | 5.45e-07 | 1024 | 151 | 18 | 24711643 |
| Pubmed | 7.78e-07 | 17 | 151 | 4 | 23955340 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 7.97e-07 | 5 | 151 | 3 | 17855024 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SART3 COPG1 TCOF1 GAPDH MYCBP2 PAK5 PSMC2 PARVB RRBP1 DCTN1 GET4 PIK3C3 PDS5A CCAR2 ASXL2 GCN1 DYNC1H1 HSPB1 MAP3K2 SON | 8.09e-07 | 1284 | 151 | 20 | 17353931 |
| Pubmed | SPAST UBQLN1 DSCAM TTC28 TCOF1 MYCBP2 PARVB DZIP1 HUWE1 RRBP1 DCTN1 BHLHE40 ZNF34 THOP1 SBNO1 FEZ1 TAF1 TNKS2 GPRASP2 DYNC1H1 | 8.19e-07 | 1285 | 151 | 20 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 DNHD1 COPG1 TCOF1 GAPDH HUWE1 RRBP1 DCTN1 STAU1 IARS2 SNW1 SBNO1 UTP20 PDS5A CCAR2 SPEN GCN1 DHX29 HCFC1 DYNC1H1 HSPB1 | 1.02e-06 | 1425 | 151 | 21 | 30948266 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TTC28 BMP2K KATNB1 PSMC2 NBN DCTN1 DNAH7 PAIP1 CEP164 RIMBP3 IARS2 PTPN14 ARFGAP3 N4BP2 PEX5 DYNC1H1 | 1.05e-06 | 853 | 151 | 16 | 28718761 |
| Pubmed | 1.08e-06 | 42 | 151 | 5 | 27578003 | ||
| Pubmed | TTC28 REST HUWE1 SNW1 N4BP2 PDS5A CCAR2 CDT1 SPEN GCN1 HCFC1 TP53BP1 | 1.09e-06 | 469 | 151 | 12 | 27634302 | |
| Pubmed | CACNB2 DSCAM TCOF1 MYCBP2 PAK5 SH3KBP1 HUWE1 HCN2 DCTN1 SNW1 SHANK2 ARVCF N4BP2 PEX5 CCAR2 DYNC1H1 TP53BP1 | 1.09e-06 | 963 | 151 | 17 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ZBTB16 SPAST CARMIL2 TTC28 MYCBP2 PAK5 WWTR1 DZIP1 DNAH7 E2F8 STIM1 PTPN14 PIK3C3 N4BP2 TET1 MAP3K2 | 1.19e-06 | 861 | 151 | 16 | 36931259 |
| Pubmed | 1.51e-06 | 320 | 151 | 10 | 28685749 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | COPG1 GAPDH PSMC2 NBN PARVB HUWE1 ARFIP1 DCTN1 SNW1 GCN1 DYNC1H1 HSPB1 SYMPK | 1.73e-06 | 582 | 151 | 13 | 20467437 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SART3 TTC28 COPG1 TCOF1 MYCBP2 PSMC2 HUWE1 PAIP1 STRIP2 TAF6L GET4 ASXL2 GCN1 HCFC1 GPRASP2 HSPB1 TP53BP1 | 1.93e-06 | 1005 | 151 | 17 | 19615732 |
| Pubmed | ZBTB16 UBQLN1 RNF168 MYCBP2 PSMC2 HUWE1 RRBP1 DCTN1 STAU1 ASXL2 TNKS2 DYNC1H1 SON | 2.04e-06 | 591 | 151 | 13 | 15231748 | |
| Pubmed | TTC28 MYCBP2 HUWE1 DCTN1 ZFHX4 N4BP2 TET1 TAF1 GCN1 GPRASP2 HSPB1 | 2.36e-06 | 418 | 151 | 11 | 34709266 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 3.12e-06 | 271 | 151 | 9 | 32433965 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.19e-06 | 203 | 151 | 8 | 22083510 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 TCOF1 GAPDH PSMC2 NBN RRBP1 ARFIP1 DCTN1 STAU1 IARS2 SNW1 GCN1 DHX29 HCFC1 TP53BP1 SON | 3.37e-06 | 934 | 151 | 16 | 33916271 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UBQLN1 COPG1 TCOF1 PSMC2 HUWE1 STIM1 RAB3GAP1 GET4 CSTF2 UTP20 PDS5A GCN1 GPRASP2 DYNC1H1 HSPB1 SYMPK | 3.75e-06 | 942 | 151 | 16 | 31073040 |
| Pubmed | UBQLN1 COPG1 TCOF1 GAPDH MYCBP2 PSMC2 RRBP1 PAIP1 PIGT THOP1 PIK3C3 PDS5A CCAR2 TAP1 HCFC1 DYNC1H1 HSPB1 TP53BP1 KIF22 | 3.80e-06 | 1297 | 151 | 19 | 33545068 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | GAPDH STAU1 SBNO1 CSTF2 CCAR2 GCN1 HCFC1 DYNC1H1 HSPB1 SYMPK | 3.99e-06 | 357 | 151 | 10 | 37059091 |
| Pubmed | 4.02e-06 | 25 | 151 | 4 | 29487109 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 4.25e-06 | 211 | 151 | 8 | 17314511 | |
| Pubmed | TTC28 COPG1 TCOF1 PSMC2 HUWE1 ARFIP1 STAU1 RAB3GAP1 ARFGAP3 GCN1 GPRASP2 | 4.67e-06 | 449 | 151 | 11 | 31732153 | |
| Pubmed | SART3 COPG1 PSMC2 HUWE1 DCTN1 STAU1 PDS5A CCAR2 GCN1 DYNC1H1 HSPB1 SON SYMPK | 4.68e-06 | 638 | 151 | 13 | 33239621 | |
| Pubmed | 5.11e-06 | 288 | 151 | 9 | 23383273 | ||
| Pubmed | CACNB2 BMP2K CYP17A1 HUWE1 PTCH1 ARFIP1 DCTN1 E2F8 CHST8 THOP1 TET1 CSTF2 ASXL2 SUCO VPS13B LRRC18 TP53BP1 | 5.28e-06 | 1084 | 151 | 17 | 11544199 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 SART3 UBQLN1 COPG1 GAPDH PSMC2 HUWE1 ARFIP1 PAIP1 RAB3GAP1 THOP1 GET4 SBNO1 CSTF2 PEX5 CCAR2 GCN1 PLS1 HCFC1 DYNC1H1 | 5.35e-06 | 1455 | 151 | 20 | 22863883 |
| Pubmed | SART3 TCOF1 GAPDH PSMC2 HUWE1 RRBP1 DCTN1 PAIP1 STAU1 PTPN14 PDS5A CDT1 DHX29 GPRASP2 HSPB1 KIF22 | 5.49e-06 | 971 | 151 | 16 | 33306668 | |
| Pubmed | The histone demethylase LSD1/KDM1A promotes the DNA damage response. | 6.61e-06 | 9 | 151 | 3 | 24217620 | |
| Pubmed | Sonic Hedgehog mediator Gli2 regulates bladder mesenchymal patterning. | 6.61e-06 | 9 | 151 | 3 | 18710724 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZXDC RTL6 MYCBP2 PARVB ZFPM1 HUWE1 PTCH1 DCTN1 GET4 SHANK2 ARVCF BANP SPEN GCN1 HCFC1 DYNC1H1 SYMPK | 6.78e-06 | 1105 | 151 | 17 | 35748872 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | COPG1 TCOF1 PSMC2 HKDC1 HUWE1 RRBP1 DCTN1 EHHADH CSTF2 CCAR2 SPEN HCFC1 DYNC1H1 | 7.30e-06 | 665 | 151 | 13 | 30457570 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTC28 BMP2K MYCBP2 PSMC2 HUWE1 RRBP1 ATL1 STAU1 STIM1 RAB3GAP1 IARS2 PTPN14 GET4 ARFGAP3 PEX5 CCAR2 SUCO VPS13B HSPB1 SON | 8.05e-06 | 1496 | 151 | 20 | 32877691 |
| Pubmed | 9.71e-06 | 312 | 151 | 9 | 37120454 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | HUWE1 SIX4 SNW1 ZFHX4 NFATC2 BANP PDS5A CCAR2 TAF1 HCFC1 TP53BP1 SON | 9.97e-06 | 583 | 151 | 12 | 29844126 |
| Pubmed | 1.29e-05 | 11 | 151 | 3 | 20081839 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 COPG1 TCOF1 GAPDH PSMC2 HUWE1 RRBP1 DCTN1 STIM1 THOP1 SNW1 SBNO1 PDS5A CCAR2 GCN1 HCFC1 DYNC1H1 HSPB1 SON | 1.30e-05 | 1415 | 151 | 19 | 28515276 |
| Pubmed | TCOF1 NBN HUWE1 RRBP1 ZXDA SPEN DHX29 HCFC1 HSPB1 TP53BP1 SON | 1.35e-05 | 503 | 151 | 11 | 16964243 | |
| Pubmed | TTC28 TCOF1 GAPDH PSMC2 RRBP1 ARFIP1 STAU1 STIM1 PDS5A GCN1 DHX29 HCFC1 DYNC1H1 | 1.42e-05 | 708 | 151 | 13 | 39231216 | |
| Pubmed | SART3 UBQLN1 GAPDH TRO TNS2 TAF6L CSTF2 ROBO2 LTBP1 TAF1 SPEN RAI2 | 1.51e-05 | 608 | 151 | 12 | 16713569 | |
| Pubmed | Vsx2/Chx10 ensures the correct timing and magnitude of Hedgehog signaling in the mouse retina. | 1.72e-05 | 12 | 151 | 3 | 18417110 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19777325 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 26600529 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 36229920 | ||
| Pubmed | Excitation creates a distributed pattern of cortical suppression due to varied recurrent input. | 1.87e-05 | 2 | 151 | 2 | 37865083 | |
| Pubmed | Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity. | 1.87e-05 | 2 | 151 | 2 | 18477452 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 29583087 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 34618999 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 34294689 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 26208798 | ||
| Pubmed | Copy number variations in SPAST and ATL1 are rare among Brazilians. | 1.87e-05 | 2 | 151 | 2 | 36537231 | |
| Pubmed | Novel SPG3A and SPG4 mutations in two patients with Silver syndrome. | 1.87e-05 | 2 | 151 | 2 | 19730024 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16815977 | ||
| Pubmed | Three novel mutations in 20 patients with hereditary spastic paraparesis. | 1.87e-05 | 2 | 151 | 2 | 29907907 | |
| Pubmed | Dynactin functions as both a dynamic tether and brake during dynein-driven motility. | 1.87e-05 | 2 | 151 | 2 | 25185702 | |
| Pubmed | Dynein drives nuclear rotation during forward progression of motile fibroblasts. | 1.87e-05 | 2 | 151 | 2 | 18782860 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 33683198 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 28716903 | ||
| Pubmed | Treacher Collins syndrome TCOF1 protein cooperates with NBS1 in the DNA damage response. | 1.87e-05 | 2 | 151 | 2 | 25512513 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 31594988 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16339213 | ||
| Pubmed | Novel SPG3A and SPG4 mutations in dominant spastic paraplegia families. | 1.87e-05 | 2 | 151 | 2 | 18664244 | |
| Pubmed | Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers. | 1.87e-05 | 2 | 151 | 2 | 29046483 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9926939 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25454648 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 23525682 | ||
| Pubmed | Dynamic regulation of the Stra13/Sharp/Dec bHLH repressors in mammary epithelium. | 1.87e-05 | 2 | 151 | 2 | 15108316 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25552654 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART3 GAPDH CCDC174 NBN RRBP1 STAU1 SNW1 CSTF2 PDS5A TAF1 SPEN HCFC1 TP53BP1 SON SYMPK | 1.89e-05 | 954 | 151 | 15 | 36373674 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | SART3 MYCBP2 PSMC2 HUWE1 SNW1 BANP CSTF2 CCAR2 CDT1 HCFC1 HSPB1 SON | 1.95e-05 | 624 | 151 | 12 | 33729478 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.96e-05 | 341 | 151 | 9 | 32971831 | |
| Pubmed | 2.08e-05 | 76 | 151 | 5 | 27542412 | ||
| Pubmed | 2.13e-05 | 128 | 151 | 6 | 23858473 | ||
| Pubmed | 2.22e-05 | 13 | 151 | 3 | 32645369 | ||
| Pubmed | 2.22e-05 | 13 | 151 | 3 | 34887903 | ||
| Pubmed | Gli2 influences proliferation in the developing lung through regulation of cyclin expression. | 2.22e-05 | 13 | 151 | 3 | 19574535 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SART3 COPG1 TCOF1 PSMC2 TNS2 HUWE1 SIX4 PTPN14 THOP1 GET4 SNW1 CCAR2 GCN1 DHX29 PLS1 | 2.40e-05 | 974 | 151 | 15 | 28675297 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.41e-05 | 268 | 151 | 8 | 33024031 | |
| Pubmed | SART3 TCOF1 MYCBP2 NBN DZIP1 RRBP1 ARFIP1 DCTN1 STAU1 STIM1 RAB3GAP1 IARS2 PTPN14 SNW1 N4BP2 SUCO DHX29 VPS13B TP53BP1 | 2.58e-05 | 1487 | 151 | 19 | 33957083 | |
| Interaction | YWHAG interactions | SYNPO2 ATP6V0B LNX2 SPAST CARMIL2 TTC28 GAPDH MYCBP2 PAK5 TNS2 WWTR1 DZIP1 HUWE1 DNAH7 E2F8 STIM1 IARS2 PTPN14 NFATC2 PIK3C3 N4BP2 TET1 SUCO GPRASP2 DYNC1H1 MAP3K2 SON | 4.27e-07 | 1248 | 149 | 27 | int:YWHAG |
| Interaction | HDAC1 interactions | ZBTB16 TTC28 GAPDH MYCBP2 PSMC2 CCND1 ZFPM1 REST DCTN1 BHLHE40 STAU1 TAF6L ZFHX4 NFATC2 GLI3 TET1 BANP CCAR2 TAF1 SPEN GCN1 HCFC1 GPRASP2 HSPB1 SYMPK | 5.67e-07 | 1108 | 149 | 25 | int:HDAC1 |
| Interaction | TRIM28 interactions | SART3 REXO5 COPG1 GAPDH MYCBP2 PSMC2 CCND1 VPS16 REST HUWE1 PTCH1 DCTN1 STAU1 ZNF34 RAB3GAP1 IARS2 PIK3C3 ZNF253 CSTF2 UTP20 PDS5A CCAR2 ASXL2 GCN1 DHX29 HCFC1 DYNC1H1 TP53BP1 SON | 1.05e-06 | 1474 | 149 | 29 | int:TRIM28 |
| Interaction | PLK1 interactions | DNHD1 MYCBP2 PAK5 TNS2 WWTR1 REST DCTN1 STIM1 PTPN14 GET4 SNW1 NFATC2 FEZ1 GPRASP2 TP53BP1 MAP3K2 | 1.24e-06 | 510 | 149 | 16 | int:PLK1 |
| Interaction | SIRT7 interactions | SART3 COPG1 TCOF1 MYCBP2 PSMC2 HUWE1 STAU1 IARS2 SNW1 UTP20 PDS5A CCAR2 SPEN GCN1 HCFC1 DYNC1H1 TP53BP1 SON SYMPK | 2.56e-06 | 744 | 149 | 19 | int:SIRT7 |
| Interaction | BICD1 interactions | SYNPO2 DSCAM TTC28 NBN HCN2 DCTN1 CEP164 PTPN14 ARFGAP3 N4BP2 FGFR4 | 2.63e-06 | 250 | 149 | 11 | int:BICD1 |
| Interaction | SYNGAP1 interactions | CACNB2 LNX2 DSCAM MYCBP2 SH3KBP1 HUWE1 RRBP1 STRIP2 SHANK2 DHX29 DYNC1H1 TP53BP1 | 3.11e-06 | 307 | 149 | 12 | int:SYNGAP1 |
| Interaction | RCOR1 interactions | TTC28 MYCBP2 CCND1 REST HUWE1 DCTN1 ZFHX4 NFATC2 TET1 TAF1 SPEN GCN1 GPRASP2 HSPB1 TP53BP1 | 4.05e-06 | 494 | 149 | 15 | int:RCOR1 |
| Interaction | BRCA1 interactions | SART3 DNHD1 RNF168 TTC28 COPG1 TCOF1 GAPDH PSMC2 TNS2 NBN CCND1 HUWE1 DCTN1 STAU1 CSTF2 PEX5 PDS5A CCAR2 TNKS2 GCN1 HCFC1 DYNC1H1 HSPB1 TP53BP1 KIF22 | 4.87e-06 | 1249 | 149 | 25 | int:BRCA1 |
| Interaction | NUDC interactions | GAPDH KATNB1 WWTR1 HUWE1 DNAH7 STAU1 SNW1 NFATC2 PDS5A DYNC1H1 TP53BP1 SYMPK | 8.05e-06 | 337 | 149 | 12 | int:NUDC |
| Interaction | DUSP16 interactions | TRO PSMC2 VPS16 CEP164 RAB3GAP1 ARFGAP3 N4BP2 PEX5 DYNC1H1 HSPB1 | 1.10e-05 | 237 | 149 | 10 | int:DUSP16 |
| Interaction | PSMD11 interactions | ZBTB16 UBQLN1 RNF168 GAPDH PSMC2 HUWE1 PTCH1 DCTN1 SNW1 CCAR2 SUCO DYNC1H1 | 1.28e-05 | 353 | 149 | 12 | int:PSMD11 |
| Interaction | MOB3C interactions | SART3 UBQLN1 GAPDH PSMC2 HUWE1 DCTN1 PTPN14 PDS5A CCAR2 GCN1 HCFC1 DYNC1H1 | 1.74e-05 | 364 | 149 | 12 | int:MOB3C |
| Interaction | RAB3GAP2 interactions | 1.77e-05 | 152 | 149 | 8 | int:RAB3GAP2 | |
| Interaction | YWHAH interactions | SPAST CARMIL2 TTC28 MYCBP2 PAK5 PSMC2 TNS2 WWTR1 DZIP1 HUWE1 DCTN1 DNAH7 E2F8 STIM1 IARS2 PTPN14 PIK3C3 TET1 CCAR2 SUCO HSPB1 MAP3K2 | 2.02e-05 | 1102 | 149 | 22 | int:YWHAH |
| Interaction | ZNF598 interactions | COPG1 TCOF1 GAPDH PAK5 PSMC2 WWTR1 REST DCTN1 STAU1 CCAR2 LTBP1 GCN1 SYMPK | 2.16e-05 | 435 | 149 | 13 | int:ZNF598 |
| Interaction | EMD interactions | SPAST COPG1 ZNF165 PAK5 ANO10 HUWE1 RRBP1 ATL1 STIM1 RAB3GAP1 NFATC2 ARFGAP3 ASXL2 FGFR4 SUCO TAP1 VPS13B HSPB1 | 2.20e-05 | 789 | 149 | 18 | int:EMD |
| Interaction | RBBP7 interactions | TTC28 TCOF1 GAPDH MYCBP2 WWTR1 ZFPM1 REST HUWE1 THOP1 SNW1 TET1 SPEN HCFC1 SYMPK | 2.48e-05 | 507 | 149 | 14 | int:RBBP7 |
| Interaction | YWHAQ interactions | CARMIL2 TTC28 GAPDH MYCBP2 PAK5 WWTR1 DZIP1 DNAH7 E2F8 STAU1 IARS2 PTPN14 NFATC2 PIK3C3 TET1 CCAR2 FGG SUCO GCN1 DYNC1H1 HSPB1 MAP3K2 | 2.52e-05 | 1118 | 149 | 22 | int:YWHAQ |
| Interaction | POU5F1 interactions | COPG1 TCOF1 GAPDH NBN HUWE1 STAU1 TET1 CCAR2 TAF1 GCN1 DHX29 HCFC1 DYNC1H1 TP53BP1 SYMPK | 2.92e-05 | 584 | 149 | 15 | int:POU5F1 |
| Interaction | SUMO2 interactions | RNF168 COPG1 GAPDH NBN HUWE1 SNW1 PDS5A CCAR2 TAF1 GCN1 HCFC1 DYNC1H1 HSPB1 TP53BP1 SYMPK | 3.35e-05 | 591 | 149 | 15 | int:SUMO2 |
| Interaction | KEAP1 interactions | ZBTB16 COPG1 GAPDH WWTR1 CCND1 HUWE1 STAU1 GET4 PIK3C3 TAF1 GPRASP2 | 3.76e-05 | 332 | 149 | 11 | int:KEAP1 |
| Interaction | OBSL1 interactions | PRUNE2 CACNA1B TCOF1 GAPDH PAK5 TNS2 HUWE1 SNW1 CSTF2 UTP20 CCAR2 SPEN GCN1 DHX29 GPRASP2 DYNC1H1 HSPB1 SON KIF22 | 3.83e-05 | 902 | 149 | 19 | int:OBSL1 |
| Interaction | ITGB3 interactions | 3.95e-05 | 170 | 149 | 8 | int:ITGB3 | |
| Interaction | YWHAE interactions | ATP6V0B CARMIL2 TTC28 GAPDH MYCBP2 PAK5 TNS2 WWTR1 HUWE1 DCTN1 E2F8 STIM1 IARS2 PTPN14 NFATC2 TET1 CCAR2 LTBP1 ASXL2 DYNC1H1 HSPB1 GPRIN2 MAP3K2 | 4.97e-05 | 1256 | 149 | 23 | int:YWHAE |
| Interaction | RBBP5 interactions | 5.62e-05 | 287 | 149 | 10 | int:RBBP5 | |
| Interaction | PML interactions | SART3 ZBTB16 GAPDH PAK5 NBN RRBP1 BHLHE40 STAU1 SNW1 SBNO1 BANP UTP20 PDS5A GCN1 TAP1 HCFC1 HSPB1 TP53BP1 SYMPK | 6.02e-05 | 933 | 149 | 19 | int:PML |
| Interaction | FOXB1 interactions | 6.59e-05 | 135 | 149 | 7 | int:FOXB1 | |
| Interaction | HDAC2 interactions | ZBTB16 BMP2K MYCBP2 CCDC174 CCND1 ZFPM1 REST HUWE1 DCTN1 STIM1 SNW1 TET1 UTP20 LTBP1 SPEN HCFC1 DYNC1H1 SYMPK | 7.26e-05 | 865 | 149 | 18 | int:HDAC2 |
| Interaction | RNF126 interactions | 7.57e-05 | 138 | 149 | 7 | int:RNF126 | |
| Interaction | KCNA3 interactions | CACNA1B DNHD1 TTC28 TCOF1 GAPDH COL27A1 PSMC2 RRBP1 ARFIP1 STAU1 STIM1 TAF6L PDS5A SPEN GCN1 DHX29 HCFC1 DYNC1H1 | 7.93e-05 | 871 | 149 | 18 | int:KCNA3 |
| Interaction | CAPZA1 interactions | CARMIL2 SH3KBP1 WWTR1 HUWE1 DCTN1 STAU1 SNW1 ASXL2 PLS1 DYNC1H1 TP53BP1 | 9.01e-05 | 366 | 149 | 11 | int:CAPZA1 |
| Interaction | SLX4 interactions | GAPDH NBN STAU1 SNW1 SBNO1 CSTF2 PDS5A CCAR2 GCN1 HCFC1 DYNC1H1 HSPB1 TP53BP1 SYMPK | 9.10e-05 | 572 | 149 | 14 | int:SLX4 |
| Interaction | PSMD2 interactions | ZBTB16 UBQLN1 DSCAM PSMC2 NBN HUWE1 PTCH1 STAU1 SNW1 PDS5A CCAR2 TP53BP1 | 9.71e-05 | 435 | 149 | 12 | int:PSMD2 |
| Interaction | SLIT2 interactions | 1.03e-04 | 63 | 149 | 5 | int:SLIT2 | |
| Interaction | YWHAZ interactions | SYNPO2 LNX2 CARMIL2 TTC28 MYCBP2 PAK5 WWTR1 DZIP1 HUWE1 DCTN1 E2F8 STAU1 STIM1 PTPN14 NFATC2 PIK3C3 CCAR2 ASXL2 SUCO DYNC1H1 HSPB1 TP53BP1 MAP3K2 | 1.04e-04 | 1319 | 149 | 23 | int:YWHAZ |
| Interaction | FOXL1 interactions | 1.07e-04 | 196 | 149 | 8 | int:FOXL1 | |
| Interaction | AR interactions | SART3 ZBTB16 GAPDH MYCBP2 PSMC2 CCND1 HUWE1 TAF6L SNW1 GLI3 PDS5A CCAR2 TAF1 GCN1 HCFC1 DYNC1H1 HSPB1 SON SYMPK | 1.35e-04 | 992 | 149 | 19 | int:AR |
| Interaction | SH3PXD2B interactions | 1.48e-04 | 68 | 149 | 5 | int:SH3PXD2B | |
| Interaction | TTC23 interactions | 1.62e-04 | 208 | 149 | 8 | int:TTC23 | |
| Interaction | RANP1 interactions | 1.62e-04 | 3 | 149 | 2 | int:RANP1 | |
| Interaction | YAP1 interactions | UBQLN1 TCOF1 GAPDH PSMC2 WWTR1 HUWE1 RRBP1 PTCH1 ARFIP1 PTPN14 SNW1 TET1 TAF1 SPEN GCN1 HCFC1 DYNC1H1 HSPB1 MAP3K2 SYMPK | 1.67e-04 | 1095 | 149 | 20 | int:YAP1 |
| Interaction | CCT8L2 interactions | 1.69e-04 | 157 | 149 | 7 | int:CCT8L2 | |
| Interaction | YWHAB interactions | CARMIL2 TTC28 MYCBP2 PAK5 TNS2 WWTR1 DZIP1 DCTN1 E2F8 STIM1 PTPN14 NFATC2 FGFR4 SUCO GPRASP2 DYNC1H1 HSPB1 MAP3K2 SON | 1.78e-04 | 1014 | 149 | 19 | int:YWHAB |
| Interaction | ATM interactions | 1.91e-04 | 333 | 149 | 10 | int:ATM | |
| Interaction | CDC5L interactions | COPG1 GAPDH PSMC2 NBN WWTR1 PARVB HUWE1 ARFIP1 STAU1 SNW1 CDT1 SPEN GCN1 DYNC1H1 HSPB1 SON SYMPK | 2.00e-04 | 855 | 149 | 17 | int:CDC5L |
| Interaction | KDM1A interactions | RNF168 TTC28 MYCBP2 ZFPM1 HUWE1 DCTN1 ZFHX4 NFATC2 N4BP2 TET1 PDS5A TAF1 FGG GCN1 GPRASP2 HSPB1 TP53BP1 SYMPK | 2.08e-04 | 941 | 149 | 18 | int:KDM1A |
| Interaction | FHL3 interactions | 2.19e-04 | 276 | 149 | 9 | int:FHL3 | |
| Interaction | CSTF2 interactions | 2.30e-04 | 165 | 149 | 7 | int:CSTF2 | |
| Interaction | ATXN1 interactions | ZXDC UBQLN1 COPG1 TCOF1 GAPDH PSMC2 HKDC1 HUWE1 RRBP1 DCTN1 BHLHE40 CSTF2 CCAR2 SPEN HCFC1 DYNC1H1 HSPB1 RAI2 KIF22 | 2.43e-04 | 1039 | 149 | 19 | int:ATXN1 |
| Interaction | GCN1 interactions | 2.77e-04 | 349 | 149 | 10 | int:GCN1 | |
| Interaction | SMC1A interactions | COPG1 GAPDH PSMC2 NBN HUWE1 STAU1 SNW1 CSTF2 PDS5A GCN1 TP53BP1 | 2.86e-04 | 418 | 149 | 11 | int:SMC1A |
| Interaction | ADARB1 interactions | SART3 TCOF1 NBN RRBP1 STAU1 SNW1 EHHADH CCAR2 CCDC106 GCN1 HCFC1 TP53BP1 | 2.86e-04 | 489 | 149 | 12 | int:ADARB1 |
| Interaction | CACYBP interactions | 2.99e-04 | 288 | 149 | 9 | int:CACYBP | |
| Interaction | WWTR1 interactions | TTC28 MYCBP2 NBN WWTR1 DCTN1 PTPN14 CSTF2 GCN1 HCFC1 TP53BP1 MAP3K2 | 3.10e-04 | 422 | 149 | 11 | int:WWTR1 |
| Interaction | COPG1 interactions | 3.10e-04 | 229 | 149 | 8 | int:COPG1 | |
| Interaction | PRRC2C interactions | 3.15e-04 | 290 | 149 | 9 | int:PRRC2C | |
| Interaction | SRSF2 interactions | 3.15e-04 | 290 | 149 | 9 | int:SRSF2 | |
| Interaction | ATOH1 interactions | 3.18e-04 | 80 | 149 | 5 | int:ATOH1 | |
| Interaction | DNAI2 interactions | 3.18e-04 | 80 | 149 | 5 | int:DNAI2 | |
| Interaction | HECTD1 interactions | TTC28 MYCBP2 HUWE1 RRBP1 DCTN1 STAU1 PTPN14 SNW1 PIK3C3 UTP20 CCAR2 CDT1 TAF1 GCN1 DHX29 HSPB1 SON KIF22 | 3.56e-04 | 984 | 149 | 18 | int:HECTD1 |
| Interaction | MAGED1 interactions | 3.56e-04 | 295 | 149 | 9 | int:MAGED1 | |
| Interaction | WBP2 interactions | 3.57e-04 | 82 | 149 | 5 | int:WBP2 | |
| Interaction | WDR26 interactions | 3.77e-04 | 179 | 149 | 7 | int:WDR26 | |
| Interaction | EED interactions | COPG1 BMP2K TCOF1 GAPDH MYCBP2 PSMC2 VPS16 HUWE1 DCTN1 RAB3GAP1 PTPN14 THOP1 GET4 STS UTP20 PDS5A CCAR2 SPEN HCFC1 DYNC1H1 TP53BP1 SON SYMPK | 3.91e-04 | 1445 | 149 | 23 | int:EED |
| Interaction | MTA2 interactions | ZBTB16 SH3KBP1 WWTR1 ZFPM1 DCTN1 STAU1 GET4 NFATC2 SPEN TP53BP1 SYMPK | 4.00e-04 | 435 | 149 | 11 | int:MTA2 |
| Interaction | FZR1 interactions | SART3 TCOF1 GAPDH CYP17A1 PSMC2 CCND1 HUWE1 RRBP1 DCTN1 PAIP1 STAU1 PTPN14 PDS5A CDT1 USP35 FGFR4 DHX29 GPRASP2 HSPB1 KIF22 | 4.06e-04 | 1172 | 149 | 20 | int:FZR1 |
| Interaction | TEAD2 interactions | 4.15e-04 | 130 | 149 | 6 | int:TEAD2 | |
| Interaction | HOOK1 interactions | 4.24e-04 | 240 | 149 | 8 | int:HOOK1 | |
| Interaction | PPP2R1A interactions | MYCBP2 PSMC2 TNS2 WWTR1 CCND1 STRIP2 STAU1 PTPN14 SNW1 NFATC2 CCAR2 ASXL2 TAF1 DYNC1H1 | 4.26e-04 | 665 | 149 | 14 | int:PPP2R1A |
| Interaction | LZTS2 interactions | TTC28 PAK5 SH3KBP1 NBN WWTR1 HUWE1 CEP164 STAU1 IARS2 SNW1 EHHADH N4BP2 | 4.33e-04 | 512 | 149 | 12 | int:LZTS2 |
| Cytoband | 4p14 | 3.64e-04 | 42 | 151 | 3 | 4p14 | |
| Cytoband | 4q28 | 3.81e-04 | 9 | 151 | 2 | 4q28 | |
| Cytoband | 22q11.21 | 5.13e-04 | 111 | 151 | 4 | 22q11.21 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SPAST TTC28 BMP2K MYCBP2 NBN WWTR1 CCND1 BHLHE40 PAIP1 RAB3GAP1 SNW1 PIK3C3 UTP20 PDS5A SPEN SUCO VPS13B TP53BP1 SON | 4.28e-07 | 856 | 149 | 19 | M4500 |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_UP | 7.21e-06 | 174 | 149 | 8 | M8186 | |
| Coexpression | GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN | 1.59e-05 | 194 | 149 | 8 | M7568 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | SPAST HUWE1 ZXDA N4BP2 ZNF253 PDS5A ASXL2 DYNC1H1 VPS13B SON | 1.16e-09 | 193 | 150 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.10e-08 | 194 | 150 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-08 | 161 | 150 | 8 | f470b662566131dfe69a2fd01186ac8491196396 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.82e-07 | 180 | 150 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.64e-07 | 189 | 150 | 8 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.22e-07 | 194 | 150 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.35e-07 | 195 | 150 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 4.06e-07 | 200 | 150 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.06e-07 | 200 | 150 | 8 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.06e-07 | 200 | 150 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.11e-06 | 158 | 150 | 7 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-06 | 173 | 150 | 7 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-06 | 174 | 150 | 7 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-06 | 175 | 150 | 7 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-06 | 181 | 150 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.96e-06 | 183 | 150 | 7 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 185 | 150 | 7 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 185 | 150 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.41e-06 | 187 | 150 | 7 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.92e-06 | 191 | 150 | 7 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.92e-06 | 191 | 150 | 7 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.06e-06 | 192 | 150 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.20e-06 | 193 | 150 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.35e-06 | 194 | 150 | 7 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 195 | 150 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.81e-06 | 197 | 150 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.14e-06 | 199 | 150 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_3|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-06 | 200 | 150 | 7 | 55a1df656545ff078b727d55e4d65d61ddb5c41f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.50e-05 | 156 | 150 | 6 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 157 | 150 | 6 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.55e-05 | 157 | 150 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.67e-05 | 159 | 150 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-05 | 159 | 150 | 6 | b1d5ebd0c186b6d0279dab20d8f3b4a915acdc1f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 166 | 150 | 6 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 168 | 150 | 6 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 168 | 150 | 6 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 169 | 150 | 6 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 172 | 150 | 6 | a7fd4d61fb5017dce001d69d6b9a01e6cdf58828 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 177 | 150 | 6 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-05 | 177 | 150 | 6 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.35e-05 | 180 | 150 | 6 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.45e-05 | 181 | 150 | 6 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 181 | 150 | 6 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-05 | 183 | 150 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 3.79e-05 | 184 | 150 | 6 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.90e-05 | 185 | 150 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.90e-05 | 185 | 150 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.02e-05 | 186 | 150 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.14e-05 | 187 | 150 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.14e-05 | 187 | 150 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.27e-05 | 188 | 150 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.27e-05 | 188 | 150 | 6 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-05 | 188 | 150 | 6 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.27e-05 | 188 | 150 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 189 | 150 | 6 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.40e-05 | 189 | 150 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 189 | 150 | 6 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 189 | 150 | 6 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.66e-05 | 191 | 150 | 6 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.66e-05 | 191 | 150 | 6 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-05 | 191 | 150 | 6 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.66e-05 | 191 | 150 | 6 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.80e-05 | 192 | 150 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 6995ee29bf403a71247de92a37dfd851be5acf2e | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.94e-05 | 193 | 150 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.94e-05 | 193 | 150 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.94e-05 | 193 | 150 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.94e-05 | 193 | 150 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.94e-05 | 193 | 150 | 6 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.08e-05 | 194 | 150 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.08e-05 | 194 | 150 | 6 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.23e-05 | 195 | 150 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 195 | 150 | 6 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.23e-05 | 195 | 150 | 6 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 195 | 150 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 150 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 150 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.38e-05 | 196 | 150 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue | 5.38e-05 | 196 | 150 | 6 | 181f3c1af565355b29f20ca6074147c313ca3477 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.53e-05 | 197 | 150 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 197 | 150 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-05 | 197 | 150 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 5.53e-05 | 197 | 150 | 6 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.53e-05 | 197 | 150 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.53e-05 | 197 | 150 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-05 | 197 | 150 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 5.53e-05 | 197 | 150 | 6 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 5.69e-05 | 198 | 150 | 6 | f540f464118edc0fb809ebcb813d0302e6952253 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.69e-05 | 198 | 150 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 5.69e-05 | 198 | 150 | 6 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.85e-05 | 199 | 150 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | SPAST CYP17A1 HKDC1 BHLHE40 CEP164 TAF6L ZNF34 ZFHX4 VPS13B GPRIN2 | 6.66e-07 | 198 | 147 | 10 | 5393_UP |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 4.92e-06 | 194 | 147 | 9 | 3245_UP | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A | 5.35e-06 | 196 | 147 | 9 | 2098_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 5.35e-06 | 196 | 147 | 9 | 5404_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 5.57e-06 | 197 | 147 | 9 | 4160_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 5.57e-06 | 197 | 147 | 9 | 4745_DN | |
| Drug | roxarsone | 1.90e-05 | 25 | 147 | 4 | CID000005104 | |
| Drug | Coal Tar | TCOF1 GAPDH CYP17A1 CCND1 E2F8 PER3 BANP ROBO2 CDT1 TAF1 HSPB1 | 2.31e-05 | 360 | 147 | 11 | ctd:D003033 |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.57e-05 | 183 | 147 | 8 | 5613_DN | |
| Drug | 1,2,5,6-dibenzanthracene | RTL6 LNX2 ZBTB16 SLCO2B1 HKDC1 CCND1 VPS16 BHLHE40 E2F8 PER3 EHHADH ROBO2 CDT1 FGG TAP1 RAI2 KIF22 | 2.98e-05 | 837 | 147 | 17 | ctd:C026486 |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.12e-05 | 188 | 147 | 8 | 6735_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.37e-05 | 190 | 147 | 8 | 3379_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.49e-05 | 191 | 147 | 8 | 5567_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 3.63e-05 | 192 | 147 | 8 | 4450_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 3.90e-05 | 194 | 147 | 8 | 2311_UP | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 4.05e-05 | 195 | 147 | 8 | 834_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.05e-05 | 195 | 147 | 8 | 4686_UP | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A | 4.05e-05 | 195 | 147 | 8 | 4597_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 4.05e-05 | 195 | 147 | 8 | 3923_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.05e-05 | 195 | 147 | 8 | 3972_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 4.20e-05 | 196 | 147 | 8 | 5686_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 147 | 8 | 6964_UP | |
| Drug | Moxonidine [75438-57-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 4.35e-05 | 197 | 147 | 8 | 7343_UP | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 5284_UP | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 7008_UP | |
| Drug | Cinoxacin [28657-80-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 6257_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 4.51e-05 | 198 | 147 | 8 | 7135_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 4352_DN | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.67e-05 | 199 | 147 | 8 | 6312_DN | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; HL60; HG-U133A | 4.84e-05 | 200 | 147 | 8 | 1570_UP | |
| Drug | radicicol | 5.38e-05 | 203 | 147 | 8 | CID000005033 | |
| Disease | Malignant neoplasm of breast | ATP6V0B SPAST SLCO2B1 CYP17A1 NBN CCND1 SIX4 PTPN14 PER3 SBNO1 ARFGAP3 N4BP2 ANKRD30A UTP20 SPEN VPS13B TP53BP1 | 1.70e-05 | 1074 | 142 | 17 | C0006142 |
| Disease | Rhabdomyosarcoma | 4.76e-05 | 15 | 142 | 3 | C0035412 | |
| Disease | Bipolar Disorder | CACNA1B CACNB2 CUX2 DSCAM TRPM2 BHLHE40 SHANK2 PER3 PIK3C3 EHHADH | 1.10e-04 | 477 | 142 | 10 | C0005586 |
| Disease | Osteoarthritis, Knee | 1.37e-04 | 4 | 142 | 2 | C0409959 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 3.41e-04 | 6 | 142 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | gamma-glutamylmethionine measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0021141 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.98e-04 | 145 | 142 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | CARMIL2 TTC28 BMP2K ZDHHC14 ARMH1 PARVB ZFPM1 REST ARFIP1 PAIP1 FIG4 BANP PDS5A ASXL2 CDT1 PLS1 | 7.90e-04 | 1347 | 142 | 16 | EFO_0005192 |
| Disease | Prostatic Neoplasms | 8.27e-04 | 616 | 142 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 8.27e-04 | 616 | 142 | 10 | C0376358 | |
| Disease | Charcot-Marie-Tooth disease | 1.09e-03 | 42 | 142 | 3 | cv:C0007959 | |
| Disease | Adenoid Cystic Carcinoma | 1.41e-03 | 100 | 142 | 4 | C0010606 | |
| Disease | Psychotic Disorders | 1.46e-03 | 101 | 142 | 4 | C0033975 | |
| Disease | Drugs used in diabetes use measurement | 1.51e-03 | 255 | 142 | 6 | EFO_0009924 | |
| Disease | Salivary Gland Neoplasms | 1.52e-03 | 47 | 142 | 3 | C0036095 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.71e-03 | 49 | 142 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | dystonia (is_implicated_in) | 2.01e-03 | 14 | 142 | 2 | DOID:543 (is_implicated_in) | |
| Disease | pancreatic cancer (is_implicated_in) | 2.14e-03 | 112 | 142 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | health literacy measurement | 2.14e-03 | 53 | 142 | 3 | EFO_0010104 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 2.32e-03 | 15 | 142 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | Cleft palate, cleft lip | 2.37e-03 | 279 | 142 | 6 | EFO_0003959, HP_0000175 | |
| Disease | birth weight, parental genotype effect measurement | 2.42e-03 | 192 | 142 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | intracerebral hemorrhage | 2.64e-03 | 16 | 142 | 2 | EFO_0005669 | |
| Disease | infant expressive language ability | 2.64e-03 | 16 | 142 | 2 | EFO_0006316 | |
| Disease | Amyotrophic lateral sclerosis | 2.98e-03 | 17 | 142 | 2 | cv:C0002736 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 2.98e-03 | 17 | 142 | 2 | cv:C0270914 | |
| Disease | Squamous cell carcinoma | 3.09e-03 | 124 | 142 | 4 | C0007137 | |
| Disease | age at menopause | 3.50e-03 | 302 | 142 | 6 | EFO_0004704 | |
| Disease | urolithiasis | 3.51e-03 | 63 | 142 | 3 | MONDO_0024647 | |
| Disease | platelet component distribution width | PRUNE2 LNX2 BMP2K ZDHHC14 ZFPM1 C4orf54 STIM1 FAR2 ARVCF PDS5A | 3.66e-03 | 755 | 142 | 10 | EFO_0007984 |
| Disease | Schizophrenia | CACNA1B CACNB2 CCND1 REST BHLHE40 ARVCF SBNO1 FEZ1 PIK3C3 TET1 TAP1 | 3.71e-03 | 883 | 142 | 11 | C0036341 |
| Disease | aspartate aminotransferase measurement | CACNB2 CUX2 TTC28 HKDC1 PARVB RRBP1 PTCH1 STAU1 FEZ1 FGFR4 GCN1 | 4.42e-03 | 904 | 142 | 11 | EFO_0004736 |
| Disease | Nonorganic psychosis | 4.53e-03 | 69 | 142 | 3 | C0349204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VAKMEDPLSNRAPDS | 131 | Q8N9N5 | |
| SSLQDMPKELDPSAV | 686 | Q8N163 | |
| APAMAAGNTVIAKPS | 166 | Q9H2A2 | |
| SSVLPNAPDMAQFKQ | 476 | Q9NP61 | |
| SQASLATMPEAPDVL | 76 | O00192 | |
| PAAKSPSAQLMEQVA | 1176 | Q14203 | |
| ALSSFMNPDKISAPL | 361 | O14503 | |
| SLKAMPLPLNDVAQA | 666 | Q6F5E8 | |
| KLSAAAVATMIVPVP | 311 | Q2WEN9 | |
| PSLPMFLQQAAAAKA | 291 | Q6PIY5 | |
| PARPDQASTVAVKML | 491 | P22455 | |
| MAQESPKNSAAEIPV | 1 | P53367 | |
| SAFKPAIEMQNSVPN | 521 | Q9BXX3 | |
| KAFLASLSPAMVVPE | 311 | Q9H211 | |
| DVMASAALAAEPSPL | 61 | Q8NDD1 | |
| TDVKFISNPPSMVAA | 191 | P24385 | |
| PDLQASIPSVAKAMA | 3076 | Q96M86 | |
| VPSSKEMVALSDNIP | 371 | Q8N865 | |
| DPVATLAAVMTEKSP | 1096 | Q7Z478 | |
| KVPSASPTADMAGAL | 1431 | O14529 | |
| ESISKAVASLPPEQM | 126 | P33240 | |
| ALPEPMTASEAAARK | 336 | Q9NSY1 | |
| AAETQPVTDASPMKR | 2006 | Q00975 | |
| AEQPKSMPVSEASLI | 406 | Q76L83 | |
| MSKSPPTAAAAVAQE | 6 | Q08289 | |
| PPAESQSGMALKVAA | 61 | Q9Y5P3 | |
| KLFVNAQRAAAMTPP | 896 | Q15042 | |
| LAPDQFASPMKSVVA | 786 | Q29RF7 | |
| SAAPAAPKLKIFMAQ | 826 | A6NNM3 | |
| SAAPAAPKLKIFMAQ | 826 | A6NJZ7 | |
| KISENAATEMRFPLP | 141 | O60330 | |
| MSPQVNAVFPESKAD | 576 | Q9NW15 | |
| SLLADTANRPKPMVD | 41 | Q9P286 | |
| MASAVSPANLPAVLL | 1 | P51610 | |
| MAALAAAAAATQKIP | 546 | P51610 | |
| KATPMAVADVIPVDT | 266 | Q96K12 | |
| QQPALMAAPLSLADA | 766 | Q13469 | |
| SKTALASPPATMAAN | 986 | Q13127 | |
| NPPAMATSAEKRSLV | 1031 | P10071 | |
| AVPSSDMSPAEQLKQ | 456 | Q96JK9 | |
| MVASAKSAPEIPTID | 21 | Q5VTL7 | |
| AATAKEAAKPSPAMD | 411 | Q9BVA0 | |
| VAMLKASAASPAVAL | 536 | Q8N448 | |
| KPIQSLPNMDSIFSE | 201 | Q08426 | |
| TLNMQPAPLTSEEFK | 656 | P56645 | |
| IPMNPNDDSLFKSLA | 146 | Q14651 | |
| QAMPAIELNPLSASS | 4096 | Q9NYQ8 | |
| KADTLPRVSPVAQMT | 256 | Q14766 | |
| MAAPASASQKLSPLQ | 416 | Q14807 | |
| NAPLVSRAPQTFKMD | 71 | P50542 | |
| APPASEILAKMSELV | 536 | Q8IX07 | |
| AMAAIFKIATQPTNP | 566 | Q9Y2U5 | |
| IFPNLISPNSMAKDS | 236 | Q8N456 | |
| EAPMPKLATQSNEIT | 166 | P04792 | |
| KASPPSVEDLQMLTN | 351 | Q99689 | |
| MPEIVATASKVDIAP | 1736 | Q92616 | |
| PVEKLAAMPALRSIN | 136 | Q8TCA0 | |
| SPNMANTVNAALKPL | 2236 | Q7Z6Z7 | |
| APVLMSKLSVNAPEF | 121 | Q9H074 | |
| KNAINSPMSPALVDV | 46 | Q9HBI1 | |
| PDESSKPNMIDAATL | 96 | P02679 | |
| LPHPKSMLQATAEAN | 341 | Q8WXF7 | |
| APFPSKMAQLAAICK | 431 | A0AVK6 | |
| EPPEAASSALALMNS | 46 | Q9BWC9 | |
| MASATAPAAAVPTLA | 1 | O95273 | |
| MPTAAAPIISSVQKL | 1 | Q92562 | |
| VAPMLIPHKANVDSS | 366 | P05093 | |
| DNASMPPVKVEFSLT | 2676 | P12111 | |
| KAPARALPQLSMVST | 36 | Q8WXX0 | |
| KLSASNALDPMLPAS | 326 | Q8IZC6 | |
| EVRSMANPPAAVKLA | 3306 | Q14204 | |
| PQAPTVTFKTLDDMI | 446 | Q6PII3 | |
| SDVRVKMLAAPINPS | 71 | Q9BV79 | |
| LKSVPLATAPMAEQR | 576 | Q9Y678 | |
| RTAPAAATMFQPAAK | 26 | Q04741 | |
| QKEIMPFPEASSLQS | 966 | Q9NRM1 | |
| MTSANDLAPAEASPL | 316 | O60269 | |
| LSPMVAEPSSKEAAA | 1706 | D6RIA3 | |
| AAPAATEAPKMSNAD | 941 | Q15020 | |
| APTVRNAMTSAPSKD | 136 | A3KN83 | |
| RKLVASMPLFANADP | 536 | Q9UL51 | |
| RDMAVSIPASKPQSD | 356 | Q5SV97 | |
| ASGLPAVSKAPSMDA | 271 | Q3SYA9 | |
| PPAGVKAAAASASMV | 1191 | O60469 | |
| MVQPQTSKAESPALA | 1 | Q6ICC9 | |
| KVLMATNRPDTLDPA | 316 | P35998 | |
| AAAPDSVRKMPQLTA | 476 | Q9Y6J9 | |
| LNKAAPPTAGSMAIE | 451 | O75691 | |
| ENFPAVSSPTQLIMK | 2016 | Q8WUY3 | |
| NMSLRKVPADLTPAT | 36 | Q9BXR5 | |
| DSIQVVKSMRAASPP | 306 | Q9ULQ0 | |
| EEAPAAMTAAQAKPA | 621 | Q13428 | |
| AMTAAQAKPALKIPQ | 626 | Q13428 | |
| ENLAKVFSLMDPNSP | 106 | Q7L5D6 | |
| LAKDTNPTAAVKMLP | 51 | Q2TB90 | |
| NPTAAVKMLPTFVRA | 56 | Q2TB90 | |
| VSVDEKLMPSAPVNT | 346 | O60934 | |
| SAAPAAPKLKIFMAQ | 826 | Q9UFD9 | |
| MSVLDIPSATPEKQV | 1671 | P21675 | |
| SVPAARPKTEAQAMS | 56 | Q96D09 | |
| AKRVIISAPSADAPM | 116 | P04406 | |
| PETATLFKSALMPAQ | 606 | Q8NEB9 | |
| AKAISMSRTDPPAVN | 786 | Q15678 | |
| KPKMEPAASSQAAVE | 596 | Q96B97 | |
| ATAPNKNSTKPLDMA | 306 | Q13635 | |
| EPTSNMDIFPTVAKL | 396 | P08842 | |
| DIADSQPMSAPVASK | 636 | Q9UIU6 | |
| AKSSQVAIEALSAMP | 361 | Q03518 | |
| LEPAKQAMSPSVAEC | 3016 | O75592 | |
| DKASPLLPANHVTMA | 371 | Q9NSE4 | |
| LMAAKRSSGAAPAPA | 86 | Q9UBP0 | |
| KPPQMSRAADEALNA | 536 | Q13586 | |
| AVPMNAPALHTLETK | 471 | Q86YF9 | |
| VPASKPSRAAENMAV | 776 | Q9UPX8 | |
| EMNKETLPAPLSAAT | 1716 | Q9UPX8 | |
| SNSEKNSLPPVMAIS | 481 | Q8NFU7 | |
| VAPPEQLSEAALKAM | 581 | Q9UPV0 | |
| IKKMPAAATIPANSS | 116 | Q9H2A9 | |
| PNSMLLPAAASEKSE | 1246 | Q86UP3 | |
| PMKNLSDDPLALTSN | 616 | Q2QGD7 | |
| VLPNHKADAVLSMPS | 336 | Q05516 | |
| VATVPAMPQEKLASS | 121 | Q9P2E9 | |
| AALKSQPSAAQPSKM | 936 | Q9UMS6 | |
| SAKISQIPPASAMDI | 2831 | Q96T58 | |
| LSALVPSMVAAKPVD | 471 | Q969N2 | |
| RAAPNPAKATVTAMI | 441 | O95793 | |
| ATKDSLAMDPPVVNR | 51 | Q12816 | |
| DMPQDFKASLCLPTT | 151 | O94956 | |
| PTMTAALISNKPEFV | 486 | O94759 | |
| TMEGPLPSNAKAAIN | 156 | Q96IC2 | |
| IPPMVASLVKEDSNS | 351 | Q9P2H5 | |
| PAAAASAEPKIMKVT | 26 | Q9UMX0 | |
| ISNMAEPFSATDPKA | 111 | Q99437 | |
| PAASEEIFKIASMAP | 331 | Q9H269 | |
| VPLLKAPNCLSSSMQ | 16 | A6NDX5 | |
| KMEASATLTVRAPPQ | 301 | Q9HCK4 | |
| AAMPVRAADKLAPAQ | 161 | Q13573 | |
| MSPVLNSKFVPAEND | 551 | Q12888 | |
| SISENATATAAPKMP | 526 | Q9UBS9 | |
| MALPKDAIPSLSECQ | 1 | Q8IYW5 | |
| SADDVSALLTAAMPP | 786 | Q9H2K2 | |
| PQAEIARNMPSSKDT | 331 | Q92797 | |
| LSSMSPLEEEAPQAK | 506 | Q92797 | |
| PNLAEATLADVMPRK | 416 | Q8IZN3 | |
| IAKPPVMSSHFAQDL | 71 | O75346 | |
| SMAAVIGNPKLPSAV | 1481 | Q96AY4 | |
| DSLAMKNSSPEPQAL | 706 | P98168 | |
| LKIGSVAMAPQADNP | 1581 | Q7Z7G8 | |
| MATEPKKAAAQNSPE | 1 | P49910 | |
| ISPPQTAMKSAEEIN | 66 | Q9H892 | |
| AEMPDATLATLKIQP | 86 | A0A1B0GX78 | |
| ASLQKMEADVPAPAC | 621 | Q8N3L3 | |
| AAMVANFTKPTADAP | 446 | P52888 | |
| PSMTKILDSFAAAPV | 236 | P18583 | |
| EAPVPTNMSTAADLL | 1256 | Q63HR2 | |
| AMAALFLSAPPQAEV | 21 | Q8IZ26 | |
| TDLEALFNSVMNPKP | 26 | Q9GZV5 | |
| LNPTPAMAKSLTIDC | 1361 | Q86UW6 |